Man Group PLC Alaunos Therapeutics, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $68,768 - $136,561	-24,386 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $50,966 - $75,352	24,386 New	24,386 $61,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $48,047 - $125,934	-25,288 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$3.95 - $5.35 $99,887 - $135,290	25,288 New	25,288 $119,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.